Overview

Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression

Status:
Completed
Trial end date:
2010-06-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of cariprazine in the treatment of outpatients with bipolar depression.
Phase:
Phase 2
Details
Lead Sponsor:
Forest Laboratories
Collaborator:
Gedeon Richter Ltd.
Treatments:
Cariprazine